Tactile Systems Technology, Inc. (TCMD)
Nasdaq · Healthcare · Medical Devices
$22.47+1.67%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $509M
- P/E (trailing)
- 20.8
- Forward P/E
- 15.4
- 52-week range
- $14.00 – $37.77
- 52-week change
- +45.68%
- EPS (trailing)
- $1.08
- Next earnings
- Nov 2, 2026
Fiscal year to Dec 2025
- Revenue
- $330M (+12.47%)
- Net income
- $19.1M
- Operating margin
- 8.9%
- Diluted EPS
- $0.82
- Free cash flow
- $40.4M
From the company’s annual report on SEC EDGAR.
About Tactile Systems Technology, Inc.
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
Headquarters: Minneapolis, United States · 1,086 employees · tactilemedical.com